Search Results 1711-1720 of 13396 for monoclonal antibody

  1. Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL - Mayo Clinic

    ... monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma (NHL). Participation eligibility. Participant eligibility ...

  2. Fractionated Anti HLA Antibodies Role in Prevention of Sold Organ Transplant Rejection - Mayo Clinic

    About this study. The purpose of this study is to develop single chain variable fragment antibodies against HLA A2 and test their efficacy in blocking the ...

  3. Mayo researchers identify biomarker to speed diagnosis in brain and spinal cord inflammation

    When an antibody is directed against healthy tissue by a misguided immune system, as it is in this disorder, it is called an autoantibody. In autoimmune ...

  4. Cancer treatment - Mayo Clinic

    Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · Multiple myeloma · Myxofibrosarcoma ...

  5. Amyloidosis - Doctors and departments - Mayo Clinic

    Hematologist. Rochester, MN. Areas of focus: Bone marrow transplant, CAR-T cell therapy, Bispecific antibody therapy, Amyloidosis, Multiple myeloma, Waldenstrom ...

  6. Controlled Trial Evaluating Avacopan In C3 Glomerulopathy - Mayo Clinic

    Use of eculizumab or another anti-C5 antibody within 26 weeks prior to dosing. ... monoclonal spike on serum or urine protein electrophoresis or immunofixation ...

  7. Multiple myeloma - Doctors and departments - Mayo Clinic

    nstrom macroglobulinemia, Monoclonal ... Angela Dispenzieri, M.D.. Hematologist. Rochester, MN. Areas of focus: Amyloidosis, Multiple myeloma, Monoclonal ...

  8. Mayo Clinic develops neuro test that distinguishes demyelinating diseases from MS

    ... antibody is associated with disease relapses, thus warranting relapse-preventing immunotherapy. “We've learned that if patients are positive for MOG antibodies ...

  9. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody. Exclusion Criteria: - Received B-cell maturation antigen (BCMA)-targeted therapy. Note: Other protocol defined Inclusion/Exclusion ...

  10. CNS Autoantibody and Inflammatory Marker Investigation in Catatonia - Mayo Clinic

    Clinical Trials · CNS Autoantibody and Inflammatory Marker Investigation in Catatonia · More about research at Mayo Clinic · Mayo Clinic Footer.